Frontiers in neurology · 2025
Burden of comorbidities in people with multiple sclerosis: a population-based study in Catalonia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mora Toni
Аннотация
BACKGROUND: People with multiple sclerosis (MS) often present with chronic comorbidities that complicate care and affect prognosis. Population-based evidence in Europe is limited.
OBJECTIVE: To describe the prevalence of selected comorbidities among individuals with MS in Catalonia, Spain, using administrative health records.
METHODS: We analysed data from 9,998 people diagnosed with MS (2013-2017), including demographic and diagnostic information across all care levels. Prevalence estimates for 23 comorbidities were stratified by age and sex, and, where available, compared with those of the general population.
RESULTS: The MS population had a higher prevalence of psychiatric, metabolic, and autoimmune comorbidities in all age groups. Young women (18-40 years) showed increased rates of depression, anxiety, thyroid disease, and migraine, while middle-aged men (50-60 years) had higher rates of hypertension, hyperlipidaemia, and diabetes.
CONCLUSION: MS is associated with a substantial, early-onset comorbidity burden, underscoring the need for integrated, multidisciplinary care across the life course.
OBJECTIVE: To describe the prevalence of selected comorbidities among individuals with MS in Catalonia, Spain, using administrative health records.
METHODS: We analysed data from 9,998 people diagnosed with MS (2013-2017), including demographic and diagnostic information across all care levels. Prevalence estimates for 23 comorbidities were stratified by age and sex, and, where available, compared with those of the general population.
RESULTS: The MS population had a higher prevalence of psychiatric, metabolic, and autoimmune comorbidities in all age groups. Young women (18-40 years) showed increased rates of depression, anxiety, thyroid disease, and migraine, while middle-aged men (50-60 years) had higher rates of hypertension, hyperlipidaemia, and diabetes.
CONCLUSION: MS is associated with a substantial, early-onset comorbidity burden, underscoring the need for integrated, multidisciplinary care across the life course.